Care365.caYour health is one click away
Menu
Vaccine product guide

RECOMBIVAX HB

Hepatitis B surface antigen (recombinant) · Hepatitis B

Health Canada DIN 02561484. Check the product and formulation on your record before using a schedule.

Plan doses for this product →
DIN
02561484
Family
Hepatitis B
Guidance checked
2026-09-27
← All Hepatitis B products

About this vaccine

Three doses over six months; two for some adolescents.

RECOMBIVAX HB is listed under Health Canada DIN 02561484. The product record and monograph below describe this formulation; the dose schedule comes from the Canadian Immunization Guide.

At a glance

Brand
RECOMBIVAX HB
DIN
02561484
Vaccine
Hepatitis B surface antigen (recombinant)
Presentation
10 mcg / 1 mL · solution · intramuscular · 20 years and older; 11 to 15 two-dose
Live vaccine
No

Age and suitability depend on the product, the person and the reason for vaccination. Use the planner for a starting point and confirm with a healthcare professional.

Official sources

Use the DIN to confirm this exact product in Health Canada's Drug Product Database.

A listed product may not be stocked or publicly funded.

Before and after your vaccination

  • Bring your immunization record if you have one, so earlier doses can be checked.
  • Tell the healthcare professional about a serious reaction to a previous vaccine or an ingredient, and mention any health conditions or medicines that could affect your vaccination.
  • After the dose, stay where you can be observed for at least 15 minutes. Tell someone right away if you feel faint or develop symptoms of an allergic reaction.
  • Keep a record of the vaccine name, date and dose you received.

These steps come from the Canadian Immunization Guide's administration practices and acute reactions guidance.

Practical guidance for RECOMBIVAX HB

For product-specific effects and precautions, check this DIN in the Health Canada product record and monograph. The general appointment steps above apply to all vaccinations.

No directly matching Pharmasist product guide was identified for this DIN. Use the linked Health Canada record to check your exact product.

Dose schedules

These are Canadian Immunization Guide schedules associated with this DIN. The right schedule depends on age, health, prior doses and reason for vaccination. Public health recommendations may differ from a product monograph's authorized schedule.

Hepatitis B — standard three-dose series

3 doses

Standard hepatitis B series at months 0, 1 and 6.

Minimum intervals: 4 weeks between doses 1 and 2, 2 months between doses 2 and 3, and 4 months between doses 1 and 3. The age-appropriate product and dose are chosen by your healthcare professional; blood testing after the series is needed for some people.

Hepatitis B — adolescents 11 to 15 years, two doses (adult dose)

2 doses

Two adult-strength doses at months 0 and 4 to 6, for adolescents 11 to less than 16 years.

For 11 to less than 16 years of age, the standard adult dose (RECOMBIVAX HB 10 mcg, or ENGERIX-B 20 mcg) may be given as two doses, the second 4 to 6 months after the first, when a three-dose series is unlikely to be completed.

Check your dose plan →

Pregnancy and breastfeeding

Family guidance on pregnancy: Recommended for people without immunity who are at high risk of exposure.

Family guidance on breastfeeding: Use if indicated.

This guidance applies to the vaccine family. Confirm this product's details in the monograph and with your clinician. Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026.

References and product information

General information only. A suggested date is not an appointment or a prescription; a healthcare professional confirms what you need. Clinical rules reviewed on 2026-09-27.

Explore care options